This Sunday, July 23rd, the biggest world congress on AIDS, the IAS, opens in Paris. Four days of colloquia, conferences and scientific seminars to take stock of the state of science in the fight against this disease. There will be care and treatment, but also access to these treatments.
Nearly 6,000 researchers from around the world, virologists, immunologists, and geneticists are meeting in Paris this Sunday for the largest gathering in the world devoted to the fight against AIDS.
There will, of course, be a question of a hypothetical vaccine, but 34 years after the discovery of the disease, this one still seems far away. Indeed, the researchers have a major problem: the ability of the virus to conceal itself in some of our immune cells. It remains hidden, camouflaged, awaiting the end of a treatment to reappear.
The goal today is to keep the virus dormant for as long as possible by limiting the side effects of treatments. The problem is that they are heavy and expensive. Access to them can, therefore, be complicated, especially in the countries of the South.
This is, therefore, a major area of research and new solutions should be presented at this congress. One thinks thus patches to stick on the skin, which would neutralize the virus by making the economy of a daily intake of tablets.
This is one example among others, as we must not forget the prevention that has made great strides in recent years. However, scientists remain cautious, especially as funding for AIDS research is decreasing.
The idea is to try to eradicate the virus in people who are already affected and who are being treated. Something we can not do now. The second element is in the clinic, because we are at the beginning of the new long-acting antivirals, because they are going to be put into a patch or, on the contrary, a subcutaneous injection of a Product, or drugs coupled to nano particles that give a prolonged diffusion and allow to target these cells called “reservoir”.